Lots of interest in Metropolis, but we want a strategic fit: MD Ameera Shah

In a Q&A, the promoter and MD of the company talks about how the dynamics are changing in the diagnostics sector post Covid, and outlines her strategy for Metropolis 3.0

The players in the diagnostic sector have witnessed a dip in profitability as the Covid-19 business has more or less gone now, even as these firms carried the cost of manpower and infra into the fourth quarter of FY22. Speaking to Sohini Das, Metropolis promoter and MD Ameera Shah talks about how the dynamics are changing and outlines her strategy for Metropolis 3.0. She also speaks about how they are not looking at an outright sale but are open to strategic investors who may fit into the vision. Edited excerpts:

The dynamics of the diagnostics industry is changing. What is